S&P 500
(-0.30%) 5 020.48 points
Dow Jones
(0.28%) 37 923 points
Nasdaq
(-0.41%) 15 594 points
Oil
(-3.21%) $79.30
Gas
(-2.66%) $1.938
Gold
(0.69%) $2 318.70
Silver
(0.62%) $26.82
Platinum
(1.58%) $963.15
USD/EUR
(-0.08%) $0.936
USD/NOK
(-0.16%) $11.08
USD/GBP
(0.08%) $0.801
USD/RUB
(-0.05%) $93.40

Aktualne aktualizacje dla PharmaSGP Holding SE [PSG.DE]

Giełda: XETRA Sektor: Pharmaceuticals Branża: Drug Manufacturers—Specialty & Generic
Ostatnio aktualizowano30 bal. 2024 @ 18:36

0.00% 23.40

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 18:36):

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo...

Stats
Dzisiejszy wolumen 32.00
Średni wolumen 520.00
Kapitalizacja rynkowa 280.57M
EPS €0 ( 2024-04-07 )
Następna data zysków ( €0 ) 2024-05-14
Last Dividend €0.490 ( 2023-06-29 )
Next Dividend €0 ( N/A )
P/E 18.72
ATR14 €0 (0.00%)

PharmaSGP Holding SE Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PharmaSGP Holding SE Finanse

Annual 2022
Przychody: €85.82M
Zysk brutto: €76.79M (89.48 %)
EPS: €1.000
FY 2022
Przychody: €85.82M
Zysk brutto: €76.79M (89.48 %)
EPS: €1.000

Financial Reports:

No articles found.

PharmaSGP Holding SE Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0.490
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

PharmaSGP Holding SE Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.90 - Stable (1.97%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €0.450 2022-06-16
Last Dividend €0.490 2023-06-29
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 2 --
Total Paid Out €0.940 --
Avg. Dividend % Per Year 0.00% --
Score 2.99 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.90
Div. Directional Score 8.25 --
Next Divdend (Est)
(2025-03-31)
€0.393 Estimate 3.00 %
Dividend Stability
0.24 Very Poor
Dividend Score
2.99
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SZG.DE Ex Dividend Junior 2023-05-26 Annually 0 0.00%
DBK.DE Ex Dividend Junior 2023-05-18 Sporadic 0 0.00%
MBG.DE Ex Dividend Knight 2023-05-04 Annually 0 0.00%
47T.F Ex Dividend Knight 2023-09-06 Annually 0 0.00%
VOS.DE Ex Dividend Junior 2023-05-25 Sporadic 0 0.00%
EUZ.DE Ex Dividend Knight 2023-06-08 Annually 0 0.00%
OEWA.DE Ex Dividend Knight 2023-05-02 Annually 0 0.00%
ALD.DE Ex Dividend Knight 2023-08-10 Quarterly 0 0.00%
HAG.DE Ex Dividend Junior 2023-05-15 Annually 0 0.00%
RHK.DE Ex Dividend Junior 2023-06-09 Sporadic 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1541.5006.9310.00[0 - 0.5]
returnOnAssetsTTM0.1141.2006.207.44[0 - 0.3]
returnOnEquityTTM0.4511.5006.109.15[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.560.8002.211.766[1 - 3]
quickRatioTTM2.050.8002.662.13[0.8 - 2.5]
cashRatioTTM1.5461.5002.523.78[0.2 - 2]
debtRatioTTM0.00766-1.5009.87-10.00[0 - 0.6]
interestCoverageTTM5.891.0008.938.93[3 - 30]
operatingCashFlowPerShareTTM2.182.009.2710.00[0 - 30]
freeCashFlowPerShareTTM2.122.008.9410.00[0 - 20]
debtEquityRatioTTM0.0275-1.5009.89-10.00[0 - 2.5]
grossProfitMarginTTM0.9061.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.2461.0007.087.08[0.1 - 0.6]
cashFlowToDebtRatioTTM25.941.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.7420.8008.396.71[0.5 - 2]
Total Score11.60

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM18.721.0008.210[1 - 100]
returnOnEquityTTM0.4512.507.499.15[0.1 - 1.5]
freeCashFlowPerShareTTM2.122.009.2910.00[0 - 30]
dividendYielPercentageTTM2.091.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM2.182.009.2710.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2681.0005.810[0.1 - 0.5]
Total Score4.90

PharmaSGP Holding SE

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej